CTLA4 and neoplasm: In colorectal cancer mouse models, anti-CTLA-4 depletes intra-tumoral Tregs but enhances the proliferation and number of Tregs in the spleen, non-draining lymph nodes, and tumor-draining lymph nodes [53,71].